ATE298003T1 - Ein tumorsuppressor namens ts10q23.3 - Google Patents
Ein tumorsuppressor namens ts10q23.3Info
- Publication number
- ATE298003T1 ATE298003T1 AT98943394T AT98943394T ATE298003T1 AT E298003 T1 ATE298003 T1 AT E298003T1 AT 98943394 T AT98943394 T AT 98943394T AT 98943394 T AT98943394 T AT 98943394T AT E298003 T1 ATE298003 T1 AT E298003T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- tumor suppressor
- region
- demonstrated
- protein
- Prior art date
Links
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 title abstract 3
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 206010018338 Glioma Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 238000004458 analytical method Methods 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 1
- 108700024394 Exon Proteins 0.000 abstract 1
- 208000032612 Glial tumor Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 abstract 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 abstract 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 230000026731 phosphorylation Effects 0.000 abstract 1
- 238000006366 phosphorylation reaction Methods 0.000 abstract 1
- 201000001514 prostate carcinoma Diseases 0.000 abstract 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5775097P | 1997-08-26 | 1997-08-26 | |
| US8356398P | 1998-04-30 | 1998-04-30 | |
| PCT/US1998/017636 WO1999010537A1 (en) | 1997-08-26 | 1998-08-26 | A tumor suppressor designated ts10q23.3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE298003T1 true ATE298003T1 (de) | 2005-07-15 |
Family
ID=26736860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98943394T ATE298003T1 (de) | 1997-08-26 | 1998-08-26 | Ein tumorsuppressor namens ts10q23.3 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1012338B1 (de) |
| JP (3) | JP4339506B2 (de) |
| AT (1) | ATE298003T1 (de) |
| AU (1) | AU9120398A (de) |
| CA (1) | CA2301199C (de) |
| DE (1) | DE69830596T2 (de) |
| ES (1) | ES2245039T3 (de) |
| WO (1) | WO1999010537A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6482795B1 (en) | 1997-01-30 | 2002-11-19 | Myriad Genetics, Inc. | Tumor suppressor designated TS10q23.3 |
| US6262242B1 (en) * | 1997-01-30 | 2001-07-17 | Board Of Regents, The University Of Texas System | Tumor suppressor designated TS10Q23.3 |
| US6284538B1 (en) * | 1999-07-21 | 2001-09-04 | Isis Pharmaceuticals, Inc. | Antisense inhibition of PTEN expression |
| GB9918057D0 (en) * | 1999-07-30 | 1999-10-06 | Univ Bristol | Therapeutic agents |
| US7041445B2 (en) * | 1999-11-15 | 2006-05-09 | Clontech Laboratories, Inc. | Long oligonucleotide arrays |
| US20020025521A1 (en) | 1999-11-29 | 2002-02-28 | Lu Kun Ping | Pin1 as a marker for abnormal cell growth |
| AU2001265137B2 (en) * | 2000-05-30 | 2007-06-14 | Indiana University Research And Technology Corporation | Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| JP2002142765A (ja) * | 2000-07-14 | 2002-05-21 | Tosoh Corp | 新規ゲノム解析法 |
| JP6472075B2 (ja) * | 2015-02-26 | 2019-02-20 | 学校法人順天堂 | Gistの予後又は治療抵抗性の診断 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262242B1 (en) * | 1997-01-30 | 2001-07-17 | Board Of Regents, The University Of Texas System | Tumor suppressor designated TS10Q23.3 |
-
1998
- 1998-08-26 EP EP98943394A patent/EP1012338B1/de not_active Expired - Lifetime
- 1998-08-26 CA CA2301199A patent/CA2301199C/en not_active Expired - Lifetime
- 1998-08-26 ES ES98943394T patent/ES2245039T3/es not_active Expired - Lifetime
- 1998-08-26 AT AT98943394T patent/ATE298003T1/de not_active IP Right Cessation
- 1998-08-26 AU AU91203/98A patent/AU9120398A/en not_active Abandoned
- 1998-08-26 WO PCT/US1998/017636 patent/WO1999010537A1/en not_active Ceased
- 1998-08-26 JP JP2000507843A patent/JP4339506B2/ja not_active Expired - Lifetime
- 1998-08-26 DE DE69830596T patent/DE69830596T2/de not_active Expired - Lifetime
-
2008
- 2008-05-20 JP JP2008131832A patent/JP4454670B2/ja not_active Expired - Lifetime
-
2009
- 2009-12-10 JP JP2009280962A patent/JP2010051330A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999010537A1 (en) | 1999-03-04 |
| EP1012338A4 (de) | 2002-11-20 |
| DE69830596T2 (de) | 2006-03-16 |
| EP1012338A1 (de) | 2000-06-28 |
| ES2245039T3 (es) | 2005-12-16 |
| EP1012338B1 (de) | 2005-06-15 |
| JP4339506B2 (ja) | 2009-10-07 |
| JP2008263988A (ja) | 2008-11-06 |
| DE69830596D1 (de) | 2005-07-21 |
| AU9120398A (en) | 1999-03-16 |
| CA2301199A1 (en) | 1999-03-04 |
| JP2001514015A (ja) | 2001-09-11 |
| JP4454670B2 (ja) | 2010-04-21 |
| JP2010051330A (ja) | 2010-03-11 |
| CA2301199C (en) | 2013-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2366712A3 (de) | TS10Q23.3 Tumorunterdrückung | |
| Wang et al. | The covalent and three-dimensional structural of concanavalin AI Amino acid sequence of cyanogen bromide fragments F1 and F2. | |
| TR200200937T2 (tr) | Yumurtalık kanseri tedavisi için bileşimler. | |
| BRPI0315666B8 (pt) | dna de a34 e a33 do tipo 3, proteínas, seus anticorpos e métodos de tratamento usando os mesmos | |
| EA199800391A1 (ru) | Ингибирование роста опухоли антисмысловыми олигонуклеотидами к il-8 и il-8 рецептору | |
| ATE458050T1 (de) | Promotion oder inhibition von angiogenese und kardiovaskularisation | |
| ATE259648T1 (de) | Verbindungen die kolorektale krebszellen spezifisch binden und verfahren für ihre herstellung | |
| TR200101482T2 (tr) | WT1'e özgü imünoterapi için bileşimler | |
| DE69940964D1 (de) | Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums | |
| TR200003087T2 (tr) | Yeni CD19 X CD3 Spesifik polipeptidler ve kullanımları | |
| ATE224713T1 (de) | Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression | |
| HUT65373A (en) | Analytical tracers for cancer, particularly malignant breast cancer | |
| TR200003515T2 (tr) | İkame edilmiş indolinon, bunların imalatı ve ilaç olarak kullanımı | |
| DE69830596D1 (de) | Ein tumorsuppressor namens ts10q23.3 | |
| DK21985A (da) | Monoklonale antistoffer mod ikke-smaacellet lungecancer | |
| ATE175996T1 (de) | Diagnose von krebs, dessen zellen das am tyrosin phosphorylierte crkl-protein exprimieren | |
| ATE332979T1 (de) | Detektion von änderungen von tumor-suppressor genen zur diagnose von krebs | |
| Goldenring et al. | Isolation of brain Ca2+-calmodulin tubulin kinase containing calmodulin binding proteins | |
| EA200100276A1 (ru) | Рецептор цитокина zalpha11 | |
| MX9702789A (es) | Novedosas proteinas ligandos del dominio de la muerte del receptor tnf, e inhibidores de la union delos ligandos. | |
| DE69021742D1 (de) | Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck. | |
| SE9500030D0 (sv) | Method of determining metastatic potential of tumor cells | |
| WO2000050595A3 (en) | Nucleic acid molecules associated with melanoma and thyroid tumors | |
| EP0815240A4 (de) | Neue menschliche proteine, die cyclinebhängigen kinasen ähneln, sowie methoden zu deren verwendung | |
| BR0312483A (pt) | Anticorpos e seus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |